ENTRY       D09659                      Drug
NAME        Rilotumumab (USAN/INN)
FORMULA     C6464H9932N1708O2010S46
EXACT_MASS  145115.4623
MOL_WEIGHT  145205.2525
SEQUENCE    (Heavy chain)
            QVQLQESGPG LVKPSETLSL TCTVSGGSIS IYYWSWIRQP PGKGLEWIGY VYYSGSTNYN
            PSLKSRVTIS VDTSKNQFSL KLNSVTAADT AVYYCARGGY DFWSGYFDYW GQGTLVTVSS
            ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSNFGTQT YTCNVDHKPS NTKVDKTVER KCCVECPPCP APPVAGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVQFNWYVDG VEVHNAKTKP REEQFNSTFR
            VVSVLTVVHQ DWLNGKEYKC KVSNKGLPAP IEKTISKTKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPMLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            EIVMTQSPAT LSVSPGERAT LSCRASQSVD SNLAWYRQKP GQAPRLLIYG ASTRATGIPA
            RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YINWPPITFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H95, H147-H203, H260-H320, H366-H424, H222-H'222, H223-H'223, H226-H'226, H229-H'339, L23-L88, L135-L195, H134-L215)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-hepatocyte growth factor antibody
  TYPE      Monoclonal antibody
TARGET      HGF [HSA:3082] [KO:K05460]
  PATHWAY   hsa04510(3082)  Focal adhesion
            hsa05200(3082)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                HGF
                 D09659  Rilotumumab (USAN/INN)
DBLINKS     CAS: 872514-65-3
            PubChem: 124490399
///
